| 1 |
20206656 | Catechol O-methyltransferase and monoamine oxidase A genotypes, and plasma catecholamine metabolites in bipolar and schizophrenic patients. | 2010 May-Jun |
1 |
| 2 |
20477912 | Mechanisms underlying striatal vulnerability to 3-nitropropionic acid. | 2010 Jul |
1 |
| 3 |
12957500 | Cerebrospinal fluid 3,4-dihydroxyphenylacetic acid level after tolcapone administration as an indicator of nigrostriatal degeneration. | 2003 Sep |
2 |
| 4 |
11793163 | COMT-inhibition increases serum levels of dihydroxyphenylacetic acid (DOPAC) in patients with advanced Parkinson's disease. | 2002 |
3 |
| 5 |
9661138 | Reduced urinary excretion of dopamine and metabolites in chronic renal parenchymal disease. | 1998 |
4 |
| 6 |
2128511 | Effect of the new selective COMT inhibitor CGP 28014 A on the formation of 3-O-methyldopa (3OMD) in plasma of healthy subjects. | 1990 |
1 |